E. González-Reimers; Javier López-Prieto; Ricardo Pelazas-González; M.Remedios Alemán-Valls; María José de la Vega-Prieto; Carlos Jorge-Ripper; M. Carmen Durán-Castellón; F Santolaria-Fernández
(The Korean Society of Bone Metabolism, 2014-02)
Background: Sclerostin inhibits osteoblast functions, differentiations, and survival rates.
As an endogenous inhibitor of the Wnt/β-catenin pathway, the sclerostin should be re-lated to decreased bone masses, although ...